Guri Hagberg
@GuriHagberg
Followers
250
Following
1K
Statuses
746
Consultant Stroke Physician. Ph.D. Oslo University Hospital. Project leader of SIFT: Safety of thrombolysis in Factor Xa-inhibitors Trial. Mother of three + 🐶
Joined September 2014
The growing use of DOACs increasingly excludes patients with AIS from treatment with intravenous thrombolysis. FXa measurements in the ED excluding relevant concentrations led to more IVT treated patients, but DOACs might not be a contraindication after all? RCT needed #ESOC2023
0
1
21
RT @GreenJournal: This case highlights the diagnostic approach and importance of thorough clinical evaluation of young patients with intrac…
0
15
0
RT @AshuPJadhav: Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion | New England Journal of Medicine
0
31
0
RT @ESOstroke: In the latest #ESOBlog post, "Tenecteplase in the Extended Time Window," @vojtech_no explores the key question: "Where do we…
0
8
0
RT @Ash_Shoamanesh: Should patients with #stroke and device-detected subclinical #AFib (SCAF) receive OAC? Our subgroup analyses of the @A…
0
31
0
RT @NEJM: A new editorial describes the science behind a clinical trial reported by Ruff et al. in which a monoclonal antibody targeting fa…
0
55
0
RT @ShadiYaghi2: The TEMPO-2 trial led to controversy regarding the utility of thrombolysis in patients with NIHSS 0-5 who have an intracra…
0
53
0
RT @Dr_No_Charite: Thank you @BerlinStroke for choosing "Type 1 Myocardial Infarction in Patients With Acute Ischemic #Stroke" https://t.c…
0
6
0
RT @IntJStroke: 💊Anticoagulation usage & thrombolytic therapy in subjects with AF-associated ischemic stroke 📌Nearly half of those with AF…
0
9
0
RT @caseyalbin: 1/ A 75 yo man with MCI, newly diagnosed atrial fibrillation, and HTN presents with worsening confusion and blurry vision.…
0
54
0
RT @GreenJournal: Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign: Systematic Review and Individual Pat…
0
20
0
RT @IntJStroke: 🚨New Leading Opinion out now!🚨 ✍️Should We Switch to Tenecteplase for all Ischaemic Strokes? Evidence and Logistics https…
0
9
0
RT @NAsdaghi: Edoxaban is superior to DAPT in patients with Afib and Stable CAD. Exactly how a stroke neurologist think.@NEJM @StrokeAHA…
0
16
0
RT @dyavagal: Thrilled to receive the Best Abstract Award for our late breaking abstract at SVIN 24!! @AaronCalienes @NAsdaghi @JudeHassanC…
0
19
0
RT @richardbuka: 1/ FDA hearing on #andexanet alfa is tomorrow (21 Nov 2024). The documents contain some more data on thrombotic events tha…
0
72
0
RT @DavidSeiffge: Great to see our review on intracerebral haemorrhage now published in @NatRevNeurol ! Great collaboration with @SimonFaHo…
0
36
0
RT @JAMACardio: From @JAMANeuro: Is left atrial appendage occlusion a valuable treatment option for patients with atrial fibrillation and #…
0
7
0
RT @ZHeart11768530: 🔴ANTICOAGULATION REVERSAL AGENTS⤵️ #2024Review #openaccess 🔹 #FOAMed #MedEd #medstudent #para…
0
58
0
RT @FaizanK91: 🆕🚨Whether patients taking #DOACs should receive thrombolysis for ischemic stroke is uncertain‼️ Coinciding with #WSC2024, ou…
0
40
0